Viewing Study NCT01598051


Ignite Creation Date: 2025-12-24 @ 11:51 PM
Ignite Modification Date: 2026-02-27 @ 2:22 PM
Study NCT ID: NCT01598051
Status: COMPLETED
Last Update Posted: 2019-05-30
First Post: 2012-04-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Xarelto [SPAF-QOL] Post-marketing Surveillance in Japan
Sponsor: Bayer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module